
FDA clamps down on proliferation of 7-OH products
The U.S. Food and Drug Administration announced on Tuesday that it is recommending a scheduling action to control certain 7-hydroxymitragynine (7-OH) products under the Controlled Substances Act.

The U.S. Food and Drug Administration announced on Tuesday that it is recommending a scheduling action to control certain 7-hydroxymitragynine (7-OH) products under the Controlled Substances Act.

The U.S. Food and Drug Administration (FDA) has delayed its response to a citizen petition regarding nicotinamide mononucleotide (NMN), citing agency-wide staffing reductions and administrative setbacks.

A new bulletin from the Botanical Adulterants Prevention Program (BAPP) details the latest adulteration and mislabeling detected in the echinacea supply chain. It reports the presence of undeclared Echinacea species and plant parts, as well as...

An infant formula supplemented with six human milk oligosaccharides and two probiotics may support healthy, age-appropriate growth and improve gut health, according to new research.

Idiopathic musculoskeletal pain may occur in up to nearly 94% of children and adolescents in sports academies and clubs, highlighting the need for early nutrition intervention.

Premium CBD brand Goodrays just completed a £5 million Series A funding round to meet surging demand. NutraIngredients spoke with CEO and co-founder Eoin Keenan about the challenges and opportunities that lie ahead.

Scotland’s AG Barr issues its half year trading update: completing the sale of bottled water brand Strathmore and acquiring a majority stake in functional shot brand The Turmeric Co.

GROWTH ASIA SUMMIT 2025
Breast milk is known to be good for infants, but research shows probiotics in this can benefit mothers too, opening avenues for maternal-infant products

South Korean firm Cell Biotech looks to enter Thailand and The Philippines within the second half of 2025, on the back of continued performance as one of the top K-probiotic exporters.

Malaysia-based PhytoGaia is embarking on its second human clinical trial assessing the potential effects of tocotrienols and plant squalene for cellular health and telomere preservation.

Bubs Australia has appointed the former chief of Seattle-based Darigold as its new CEO as it seeks further growth in the US.